FDA Inspection 577817 — Platinum Strategies, Inc.
The FDA completed an inspection of Platinum Strategies, Inc. on Apr 9, 2009 in Bloomington, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 9, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Unapproved and Misbranded Drugs
- Location
- Bloomington, IN (United States)